Marinus Pharmaceuticals Inc (MRNS) Inventory Turnover Ratio, from third quarter 2024 to third quarter 2023, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Marinus Pharmaceuticals Inc   (NASDAQ: MRNS)
 

Marinus Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2024, Marinus Pharmaceuticals Inc 's inventory turnover ratio sequentially decreased to 0.45 in the third quarter 2024, unsurprisingly, as the Marinus Pharmaceuticals Inc markets continue to deteriorate, and MRNS's faces growing challenges to bring down its inventories. Marinus Pharmaceuticals Inc 's average inventory processing period in the Sep 30 2024 quarter, has increased to 811 days, from 745 days, in the Jun 30 2024 quarter.

Within Healthcare sector 394 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1300 in the second quarter 2024, to 1832.

MRNS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Marinus Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MRNS Inventory Turnover Ratio (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Inventory Growth 145.5 % 82.24 % 15529.73 % 3033.77 % 2530.77 %
Y / Y Cost of Sales Growth 56.92 % 90.41 % 266.99 % - 847.92 %
Inventory Turnover Ratio (TTM) 0.45 0.49 0.47 - 1.5
MRNS's Total Ranking # 1832 # 1300 # 1401 # 864 #
Average inventory processing period 819 741 777 - 243
Seq. Inventory Growth 37.84 % -15.74 % 139.66 % -11.81 % 2.32 %
Seq. Cost of Sales Growth -2.86 % -2.78 % - - 17.88 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 132
Healthcare Sector # 395
Overall Market # 1832

Inventory Turnover Ratio Statistics
High Average Low
2.31 0.96 0.45
(Jun 30 2023)   (Sep 30 2024)



MRNS Company Profile >> Back to MRNS Efficiency Comparisons >> Compare MRNS Inventory Turnover Ratio to its Competitors

Financial Statements
Marinus Pharmaceuticals Inc 's Inventories $ 7 Millions Visit MRNS's Balance sheet
Marinus Pharmaceuticals Inc 's Cost of Revenues TTM $ 2 Millions Visit MRNS's Income Statement
What are MRNS's Sales? Visit MRNS's Sales by Segment

Other Inventory Turnover Ratios
Marinus Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MRNS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MRNS's Competitors
Inventory Turnover Ratio for MRNS's Suppliers
Inventory Turnover Ratio for MRNS's Customers

You may also want to know
MRNS's Sales Growth Rates MRNS's Pe Price to earnings ratio MRNS's Receivables Turnover Ratio MRNS's Stock Quote
MRNS's Net Income Growth Rates MRNS's Ps Price to Sales ratio MRNS's Sales per Employee MRNS's Asset Turnover Ratio
MRNS's Net Margin MRNS's Pb Price to Book ratio MRNS's Financial Strength Ratios MRNS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2024 Inventories at quarter ending Sep 30 2024
Zimmer Biomet Holdings Inc   0.90 $ 2,143.400  Millions$ 2,378  Millions
Universal Biosensors Inc   0.89 $ 2.649  Millions$ 3  Millions
Creative Medical Technology Holdings Inc   0.88 $ 0.004  Millions$ 0  Millions
Insmed Inc  0.88 $ 78.034  Millions$ 89  Millions
Heron Therapeutics Inc   0.85 $ 36.988  Millions$ 43  Millions
Solana Company  0.85 $ 0.518  Millions$ 1  Millions
Delcath Systems Inc   0.85 $ 4.233  Millions$ 5  Millions
Xeris Biopharma Holdings Inc   0.83 $ 34.924  Millions$ 42  Millions
Tonix Pharmaceuticals Holding Corp   0.83 $ 8.949  Millions$ 11  Millions
Verrica Pharmaceuticals Inc   0.82 $ 1.800  Millions$ 2  Millions
Neurocrine Biosciences Inc   0.81 $ 33.200  Millions$ 41  Millions
Reflect Scientific Inc  0.81 $ 0.715  Millions$ 1  Millions
Innoviva Inc   0.79 $ 29.433  Millions$ 37  Millions
Reshape Lifesciences Inc  0.78 $ 2.603  Millions$ 3  Millions
Milestone Scientific Inc   0.77 $ 2.429  Millions$ 3  Millions
Rapid Micro Biosystems Inc   0.77 $ 16.004  Millions$ 21  Millions
Durect Corp  0.77 $ 1.816  Millions$ 2  Millions
Catheter Precision Inc   0.75 $ 0.038  Millions$ 0  Millions
Dynavax Technologies Corporation  0.75 $ 44.724  Millions$ 60  Millions
Gyre Therapeutics Inc   0.75 $ 3.957  Millions$ 5  Millions
Establishment Labs Holdings Inc   0.74 $ 52.555  Millions$ 71  Millions
Petros Pharmaceuticals inc   0.74 $ 1.106  Millions$ 2  Millions
Supernus Pharmaceuticals inc   0.73 $ 51.808  Millions$ 71  Millions
Optinose Inc   0.72 $ 7.408  Millions$ 10  Millions
Aurinia Pharmaceuticals Inc   0.72 $ 28.091  Millions$ 39  Millions
Butterfly Network Inc   0.71 $ 52.613  Millions$ 74  Millions
Paragon 28 inc   0.71 $ 67.236  Millions$ 94  Millions
Scpharmaceuticals Inc   0.71 $ 9.169  Millions$ 13  Millions
Emmaus Life Sciences Inc   0.67 $ 1.083  Millions$ 2  Millions
Hyperfine Inc   0.66 $ 4.652  Millions$ 7  Millions

Date modified: 2026-08-29T17:19:29+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.